News
Regulatory affairsRegulatory Round-up - March 2026
CGT Catapult hosts second annual workshop to address digital challenges in adoption of advanced therapies by the NHSRegulatory news - November 2019Press release: Investment in UK cell and gene therapy manufacturing set to continuePress release: Accelerated demand for specialist skills in the UK cell and gene therapy industryCGT Catapult launches commercial readiness advice clinics programme to help cell and gene therapy SMEs and spin-out companies accelerate towards commercialisationRegulatory news - October 2019Regulatory news - September 2019Cell and Gene Therapy Catapult CEO to RetirePress release: Construction completed on expansion phase, doubling capacity of Cell and Gene Therapy Catapult large scale manufacturing centre in StevenageAugust news: Where will we see you this autumn?July news: Developing novel reimbursement practicesJune news: Supporting development of cell and gene therapies
